glp 1 drug shortage GLP-1 No Longer on FDA's List GLP-1 Antagonists Increase Plan Drug
Description
Glucagon-like peptide-1 analogue and dipeptidyl peptidase-IV inhibitors
Avoid GLP-1 analogs during pregnancy and consider alternative treatment approaches (23)
doi:10.1016/j.psychres.2020.113670CrossRefGoogle Scholar Siskind, DJ, Russell, AW, Gamble, C, et al
Dipeptidyl peptidase-4 inhibitors are orally active and have a long half-life, enabling once-daily dosing
Moreover, the injectable drugs semaglutide and liraglutide presented a fourfold increased risk of bowel obstruction and a ninefold increased risk of pancreatitis compared to Contrave
